Form 4: Moderna CFO James Mock Reports Stock Transactions
SEC Form 4 Filing
Chief Financial Officer of Moderna, James Mock, reports the acquisition and disposal of common stock and restricted stock units.
Summary
- James Mock, the Chief Financial Officer of Moderna, reported transactions involving Moderna's common stock and restricted stock units (RSUs).
- On April 5, 2024, 1,453 restricted stock units converted into common stock, and Mr. Mock acquired 5,753 shares.
- On April 8, 2024, Mr. Mock disposed of 705 shares of common stock at a price of $101.9281 per share to cover tax withholding obligations related to the vesting of RSUs.
- Following these transactions, Mr. Mock beneficially owns 5,048 shares of common stock and 14,527 restricted stock units.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions by a company executive. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors regarding the buying and selling activities of company executives.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding insider trading activity.
Key Dates
| Date | Description |
|---|---|
| 10/05/2023 | 25% of restricted stock units vested. |
| 04/05/2024 | Conversion of 1,453 restricted stock units to common stock; acquisition of 5,753 shares. |
| 04/08/2024 | Sale of 705 shares at $101.9281 to cover tax obligations. |
| 04/09/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.